Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -177,478 | -120,723 | -67,992 | -243,787 | -184,968 |
| Depreciation Amortization | -2,598 | -2,009 | -1,132 | -5,088 | -4,164 |
| Accounts payable and accrued liabilities | -2,759 | -2,663 | -2,255 | 2,873 | 5,770 |
| Other Working Capital | -3,646 | -8,129 | -525 | 22,636 | 23,992 |
| Other Operating Activity | 27,996 | 21,672 | 12,456 | 40,430 | 26,774 |
| Operating Cash Flow | $-158,485 | $-111,852 | $-59,448 | $-182,936 | $-132,596 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 155 | 84 | N/A | N/A | N/A |
| Purchase Of Investment | -82,868 | -82,868 | -44,385 | -312,223 | -205,324 |
| Sale Of Investment | 208,587 | 157,341 | 88,545 | 242,441 | 234,341 |
| Other Investing Activity | 0 | 0 | 0 | -775 | -775 |
| Investing Cash Flow | $125,874 | $74,557 | $44,160 | $-70,557 | $28,242 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 18,262 | 18,398 | N/A | N/A | N/A |
| Common Stock Issued | 59 | N/A | N/A | 21,176 | 6,255 |
| Other Financing Activity | 0 | 59 | 0 | 427 | -225 |
| Financing Cash Flow | $18,321 | $18,457 | $N/A | $21,603 | $6,030 |
| Beginning Cash Position | 143,361 | 143,361 | 143,361 | 375,251 | 375,251 |
| End Cash Position | 129,071 | 124,523 | 128,073 | 143,361 | 276,927 |
| Net Cash Flow | $-14,290 | $-18,838 | $-15,288 | $-231,890 | $-98,324 |
| Free Cash Flow | |||||
| Operating Cash Flow | -158,485 | -111,852 | -59,448 | -182,936 | -132,596 |
| Capital Expenditure | -16 | 84 | N/A | N/A | N/A |
| Free Cash Flow | -158,501 | -111,768 | -59,448 | -182,936 | -132,596 |